Eligibility for long-acting cabotegravir/rilpivirine in youth aged 12-25 living with perinatally acquired HIV

被引：0
|
作者：
Ryan, Fionnuala [1 ]
Mackie, Nicola E. [2 ]
Jayadel, Hana [1 ]
Ayers, Sara [2 ]
Foster, Caroline [1 ,2 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Dept Paediat Infect Dis, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept GUM HIV Med, London, England
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
O20
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [41] Pittsburgh Sleep Quality Index (PSQI) Changes in Virologically Suppressed People Living with HIVSwitching to Long-Acting Cabotegravir and Rilpivirine
    De Gennaro, Nicolo
    Poliseno, Mariacristina
    Dargenio, Angelo
    Balena, Flavia
    Fiordelisi, Deborah
    Spada, Vito
    Romita, Greta
    Guido, Giacomo
    Di Gennaro, Francesco
    Bruno, Giuseppe
    Purgatorio, Mariantonietta
    Buccoliero, Giovanni Battista
    Saracino, Annalisa
    BIOMEDICINES, 2024, 12 (09)
  • [42] Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 infection switching to long-acting cabotegravir and rilpivirine
    Rubenstein, E.
    Diemer, M.
    Goldwirt, L.
    Lascoux-Combe, C.
    Lafaurie, M.
    Ponscarme, D.
    Denis, B.
    De Castro, N.
    Rami, A.
    Sellier, P. -O.
    Deville, L.
    Chaix, M. -L.
    Delaugerre, C.
    Molina, J. -M.
    HIV MEDICINE, 2023, 24 : 481 - 482
  • [43] The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment
    Alberton, Francesca
    Nozza, Silvia
    Raccagni, Angelo Roberto
    Galli, Laura
    Spagnuolo, Vincenzo
    Bossolasco, Simona
    Cernuschi, Massimo
    Canetti, Diana
    Hasson, Hamid
    Castagna, Antonella
    Gianotti, Nicola
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [44] Transient Viremia in Young Adults With HIV After the Switch to Long-Acting Cabotegravir and Rilpivirine: Considerations for Dosing Schedule and Monitoring
    Rakhmanina, Natella
    Richards, Kristen
    Adeline Koay, Wei Li
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 92 (03) : E14 - E17
  • [45] Cabotegravir plus Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Sension, Michael G.
    Brunet, Laurence
    Hsu, Ricky K.
    Fusco, Jennifer S.
    Cochran, Quateka
    Uranaka, Christine
    Sridhar, Gayathri
    Vannappagari, Vani
    Van Wyk, Jean
    Mccurdy, Lewis
    Wohlfeiler, Michael B.
    Fusco, Gregory P.
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (12) : 2709 - 2724
  • [46] Letter to the Editor: Real-Life Experience of Long-Acting Cabotegravir-Rilpivirine Combination in a Person Living with HIV with Detectable Viremia: A Case Report
    Ciccullo, Arturo
    Iannone, Valentina
    Lombardi, Francesca
    Borghetti, Alberto
    Di Giambenedetto, Simona
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (10) : 555 - 556
  • [47] Long-acting cabotegravir and rilpivirine in HIV individuals with a BMI over 30: a real-world study (RELATIVITY cohort)
    Troya, Jesus
    Morano, Luis
    Ignacio Bernardino, Jose
    Buzon Martin, Luis
    Pedrero Tome, Roberto
    Galindo Puerto, Maria Jose
    Torralba, Miguel
    Cabello Clotet, Noemi
    Garcia Lopez, Maria
    Lope, Silvia
    de Zarraga Fernandez, Miguel Alberto
    Cabello, Alfonso
    Aguilera Garcia, Maria
    Cecilio, Alvaro
    Diaz de Santiago, Alberto
    Garcinuno Jimenez, Maria Angeles
    Bernal, Enrique
    Lopez Caballero, Maria Teresa
    Calderon Hernaiz, Ruth
    Vivancos Gallego, Maria Jesus
    Omiste Sanvicente, Teresa
    Ferreira Pasos, Eva
    Losa Garcia, Juan Emilio
    Soler Gonzalez, Josefa Francisca
    Antonia Sepulveda, Maria
    Garcia Navarro, Maria del Mar
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 92 - 93
  • [48] Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People With HIV Who Are Virally Unsuppressed
    Hickey, Matthew D.
    Grochowski, Janet
    Mayorga-Munoz, Francis
    Oskarsson, Jon
    Imbert, Elizabeth
    Spinelli, Matthew
    Szumowski, John D.
    Appa, Ayesha
    Koester, Kimberly
    Dauria, Emily F.
    Mcnulty, Moira
    Colasanti, Jonathan
    Havlir, Diane V.
    Gandhi, Monica
    Christopoulos, Katerina A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 96 (03) : 280 - 289
  • [49] Preference-based measure of health from participants in Phase 3 studies of long-acting cabotegravir and rilpivirine for the treatment of HIV
    Wu, Sterling
    Jacob, Ian
    Van de Velde, Nicolas
    Chounta, Vasiliki
    HIV MEDICINE, 2021, 22 : 73 - 73
  • [50] Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort
    De Vito, Andrea
    Botta, Annarita
    Berruti, Marco
    Castelli, Valeria
    Lai, Vincenzo
    Cassol, Chiara
    Lanari, Alessandro
    Stella, Giulia
    Shallvari, Adrian
    Bezenchek, Antonia
    Di Biagio, Antonio
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
12345